MYLIP Antibody - Cat. #: CSB-PA855506ESR1HU

SKU: CSB-PA855506ESR1HU

Size :50ul

Clone Number:

Aliases:BM-023 antibody; BZF1 antibody; E3 ubiquitin protein ligase MYLIP antibody; E3 ubiquitin-protein ligase MYLIP antibody; Idol antibody; Inducible degrader of the LDL-receptor antibody; Lipoprotein receptor antibody; MIR antibody; MYLIP antibody; MYLIP_HUMAN antibody; Myosin regulatory light chain interacting protein antibody; PP5242 antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:Q8WY64

Immunogen:Recombinant Human E3 ubiquitin-protein ligase MYLIP protein (266-445AA)

Raised in:Rabbit

Species Reactivity:Human

Tested Applications:ELISA, IHC; Recommended dilution: IHC:1:20-1:200

Background:E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.

Clonality:Polyclonal

Isotype:IgG

Purification Method:Antigen Affinity Purified

Conjugate:Non-conjugated

Buffer:PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:MYLIP

Research Areas:Epigenetics and Nuclear Signaling; Cancer; Cardiovascular; Cell biology; Metabolism; Signal transduction